PCSK9 and metabolic dysfunction-associated steatotic liver disease: Significant association between PCSK9 and apo C3 (r = 0.44, p < 0.001) and apo B48 (r = 0.23, p < 0.05) was observed only in NAFLD patients and between PCSK9 and BMI (r = 0.39, p < 0.05) was present only in a group without NAFLD (Table 3).